Articles Tagged with ''FDA''

The American Egg Board is investing $1 million to bring more egg-based breakfast options to schools nationwide. The effort aligns with updated dietary guidance positioning eggs as a top protein choice for children’s health and development.

The FDA is giving food companies more flexibility to label products as containing “no artificial colors” when petroleum-based dyes are not used. The move, paired with new approvals for beetroot red and expanded spirulina use, supports industry efforts to shift toward naturally derived color alternatives.

The FDA is requesting industry and stakeholder input on gluten labeling and cross-contact in packaged foods. The move signals potential future regulatory action to improve transparency and consumer protection.

Senior federal health officials gathered with scientists, industry and patient advocates to spotlight food allergies as an overlooked public-health crisis. New investments, research partnerships and next-gen technologies aim to accelerate diagnostics, treatment and prevention.

The company will be presenting Harvest Bark concepts that showcase how indulgent treats can be made better-for-you while delivering bold visual appeal.

Eight synthetic dyes are on the chopping block—are your formulations ready to survive without them? Natural pigments aren’t plug-and-play, and the brands that wait will pay in cost, speed and shelf appeal. From stability and sourcing to flavor impacts and cost, natural pigments require new strategies across formulation, labeling and supply chains.

The strategy outlines targeted executive actions to advance gold-standard science, realign incentives, increase public awareness and strengthen private-sector collaboration.

Gardenia (genipin) blue can be used in processed food products, such as sports drinks, flavored water (soft drinks other than carbonated beverages), fruit juice beverages, tea drinks, hard candies and soft candies, which are manufactured and sold in the US

The Living HHS Open Data Plan will continue to be refined to empower stakeholders with HHS data with the goal of delivering improved services, maximizing the nation’s return on Federal investment through public transparency.

The FDA action is in line with US Department of Health and Human Services Secretary Robert F. Kennedy, Jr.’s priority to work with industry to phase out the use of all synthetic, petroleum-based dyes from the nation’s food supply